Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 4/20 | 0.53 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.53 |
| ▸ | PIK3CD | O00329 | 3/20 | 0.47 |
| ▸ | CHEK2 | O96017 | 2/20 | 0.45 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.43 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23355604 | 1.00 | GPR119 (0.53) | GPR119USP30PIK3CDCHEK2S1PR3 | |
| SCHEMBL1375821 | 0.93 | GPR119 (0.60) | GPR119USP30CHEK2ALDH1A1 | |
| SCHEMBL7558762 | 0.90 | GPR119 (0.52) | GPR119USP30PIK3CDCHEK2S1PR3 | |
| SCHEMBL7558767 | 0.90 | GPR119 (0.52) | GPR119USP30PIK3CDCHEK2S1PR3 | |
| SCHEMBL5089073 | 0.87 | GPR119 (0.54) | GPR119USP30PIK3CDCHEK2S1PR3 | |
| SCHEMBL15297678 | 0.87 | GPR119 (0.56) | GPR119USP30PIK3CDCHEK2S1PR3 | |
| SCHEMBL3903090 | 0.86 | USP30 (0.55) | GPR119USP30PIK3CDCHEK2S1PR3 | |
| SCHEMBL6925094 | 0.86 | GPR119 (0.53) | GPR119USP30PIK3CDCHEK2S1PR3 | |
| SCHEMBL6926563 | 0.84 | GPR119 (0.51) | GPR119USP30PIK3CDCHEK2S1PR3 | |
| SCHEMBL24394583 | 0.84 | GPR119 (0.51) | GPR119USP30PIK3CDCHEK2S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112423758-A | Adenosine receptor binding compounds | 尼康治疗公司 | 2021-02-26 | — | — | CN | disclosed |